Medicare Enrolled

Dr. Muhammad Talib, MD

Pulmonary Disease · Live Oak, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
11901 TOEPPERWEIN RD STE 1401, Live Oak, TX 78233
2105991433
In practice since 2006 (20 years)
NPI: 1700855640 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Talib from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Talib? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Talib

Dr. Muhammad Talib is a pulmonary disease in Live Oak, TX, with 20 years in practice. Based on federal Medicare data, Dr. Talib performed 2,321 Medicare services across 1,631 unique beneficiaries.

Between the years covered by Open Payments, Dr. Talib received a total of $6,195 from 40 pharmaceutical and/or device companies across 319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Talib is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 13% volume in TX$ $6,195 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,321
Medicare services
Top 13% in TX for pulmonary disease
1,631
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~116 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)869$92$300
Hospital follow-up visit, high complexity370$92$250
Office visit, established patient (20-29 min)189$62$250
Test to measure expiratory airflow and volume changes before and after medication administration145$27$150
Test to examine how well the lungs exchange gases145$39$150
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme128$0$50
Test to determine lung volumes using sensors119$40$150
Initial hospital admission, high complexity80$134$450
Hospital follow-up visit, moderate complexity67$61$200
New patient office visit (45-59 min)62$121$450
New patient office visit (30-44 min)47$70$300
Sleep study in sleep lab (6 years or older)39$446$1,500
Sleep study including heart rate, breathing, airflow, and effort33$69$250
Test to determine lung volumes using gas dilution or washout16$29$120
Telephone medical discussion with physician, 21-30 minutes12$97$300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,195
Total received (2018-2024)
Avg $885/year across 7 years
Top 30% in TX for pulmonary disease
40
Companies
319
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,136 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$60 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,046
2023
$850
2022
$711
2021
$492
2020
$275
2019
$1,922
2018
$900

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Olympus Corporation of the Americas
$990
GlaxoSmithKline, LLC.
$944
AstraZeneca Pharmaceuticals LP
$549
Actelion Pharmaceuticals US, Inc.
$532
Boehringer Ingelheim Pharmaceuticals, Inc.
$514
Grifols USA, LLC
$454
Philips Electronics North America Corporation
$163
Gilead Sciences, Inc.
$139
Takeda Pharmaceuticals U.S.A., Inc.
$131
Electromed, Inc.
$127
United Therapeutics Corporation
$118
Regeneron Healthcare Solutions, Inc.
$109
GENZYME CORPORATION
$106
JAZZ PHARMACEUTICALS INC.
$104
Advanced Respiratory, Inc
$103
Mylan Specialty L.P.
$103
Jazz Pharmaceuticals Inc.
$97
Baxter Healthcare
$92
Harmony Biosciences LLC
$91
Insmed, Inc.
$65
CSL Behring
$57
Sunovion Pharmaceuticals Inc.
$56
Fisher & Paykel Healthcare Inc
$52
PORTOLA PHARMACEUTICALS, INC.
$49
Bayer Healthcare Pharmaceuticals Inc.
$43
Shire North American Group Inc
$39
Pulmonx Corporation
$37
Inogen, Inc.
$37
Axsome Therapeutics, Inc.
$37
Harmony Biosciences Llc
$34
Napo Pharmaceuticals Inc
$31
Genentech USA, Inc.
$29
ALK-Abello, Inc
$29
Apria Healthcare LLC
$25
3B Medical, Inc.
$24
Merck Sharp & Dohme LLC
$21
Itamar Medical Inc
$17
Mallinckrodt Hospital Products Inc.
$17
Janssen Pharmaceuticals, Inc
$16
HARMONY BIOSCIENCES LLC
$14
Top 3 companies account for 40.1% of total payments
Associated products mentioned in payments ›
(7999) SRC Und · (8874) inCourage · ACTHAR · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · Arikayce · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · CHARTIS CATHETER · DUPIXENT · FASENRA · FISHER & PAYKEL HEALTHCARE · GLASSIA · Grastek · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · Hillrom - Vest System Model 105 Home Care · INOGEN · InogenOne · Invacare · LONHALA MAGNAIR · LUNA · Life 2000 Ventilation System · Mytesi · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Olympus EBUS Bronchoscopes · Perforomist · Prolastin-C · Prolastin-C Liquid · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Vest System 205 Acute Care · The Vest System Model 105 Home Care · UPTRAVI · Veklury · WAKIX · Wakix · WatchPAT · XARELTO · XYREM · XYWAV · Xolair · Xyrem · Yupelri · Zemaira
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $267 per 100 Medicare services performed
Looking for a pulmonary disease in Live Oak?
Compare pulmonary diseases in the Live Oak area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
74
Per 100K population
3.6
County median income
$70,571
Nearest hospital
LAUREL RIDGE TREATMENT CENTER
5.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Talib is a clinical cardiology specialist, with above-average Medicare volume (top 13% in TX), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Talib experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Talib performed 869 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Talib receive payments from pharmaceutical companies?
Yes. Dr. Talib received a total of $6,195 from 40 companies across 319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Talib's costs compare to other pulmonary diseases in Live Oak?
Dr. Talib's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Talib) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →